# Alpha-1 Foundation: Observational study in Alpha-1 Antitrypsin Deficiency, AATD (1000 participants)

**Score:** 55/100

| Field | Value |
|---|---|
| Sponsor | Alpha-1 Foundation |
| Sponsor type | Academic and hospital |
| Study | AATD-Liver Scan Study |
| NCT ID | NCT07898553 |
| Phase | Observational |
| Status | enrolling by invitation |
| Conditions | Alpha-1 Antitrypsin Deficiency; AATD; Alpha-1 Protease Inhibitor Deficiency; Alpha-1 AT Deficiency; Alpha-1 Antitrypsin Deficiency (AATD) |
| Target enrollment | 1000 |
| Site countries | United States |
| Posted | 2026-10-27 |
| Planned start | 2026-01-27 |
| Event | Newly registered study |
| Event date | 2026-10-27 |

## Why this score
- Posted in the last two weeks.
- 1000 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07898553). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.